𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral high-dose medroxyprogesterone acetate causes adrenal suppression in patients with breast cancer

✍ Scribed by Van Veelen, H.; Houwerzijl, J.; Roding, T.J.; Tjabbes, T.; Vermeer, R.J.I.; Sleijfer, D.Th.; Pratt, J.J.; Willemse, P.H.B.

Book ID
121891039
Publisher
Elsevier Science
Year
1982
Weight
174 KB
Volume
18
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adrenal suppression by oral high-dose me
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients
✍ Henk Veelen; Pax H. B. Willemse; Dirk T. Sleijfer; John J. Pratt; Wim J. Sluiter πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 332 KB

The effects of oral MPA, 300 mg t.i.d., on adrenal function in postmenopausal patients with disseminated breast cancer were evaluated. The levels of serum cortisol, ACTH, androstenedione, DHEA-S, LH, FSH, GH, and prolactin in 22 patients receiving MPA were compared with those in another group of 28

Mechanism of adrenal suppression by high
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients
✍ H. Veelen; P. H. B. Willemse; D. T. Sleijfer; E. Ploeg; W. J. Sluiter; H. Dooren πŸ“‚ Article πŸ“… 1985 πŸ› Springer 🌐 English βš– 362 KB

To investigate the mechanism of adrenal suppression by high-dose MPA, we performed direct and indirect stimulation tests in postmenopausal women with disseminated breast cancer who were receiving MPA and in a postmenopausal breast cancer control group. A partial adrenal insufficiency was found durin